| Pierre Fabre Pharma SA - Obgemsa 75 mg, Filmtabletten | | 69983 | | 01 | | Obgemsa 75 mg | | Filmtabletten | | G04BD15 | | Vibegron | | 20.08.2025 | | |
| | Composition | | vibegronum 75 mg, mannitolum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium max. 0.405 mg, hydroxypropylcellulosum, magnesii stearas, Überzug: lactosum monohydricum 1.575 mg, hypromellosum, E 171, triacetinum, E 132, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Vibegronum | 75 mg |
| | BAG: Active Agent | Dose |
|---|
| Vibegronum | 75 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 132 | | color. | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | | | Lactose Monohydrate | 1.575 mg | Überzug | | Magnesii Stearas | | | | Mannitol | | | | Pro Compresso Obducto | | | | Triacetinum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 30 | 30.67 | 49.75 | B | SL | No | | 002 | 90 | 89.33 | 113.55 | B | SL | No |
|
|
